Agenda/Scientific Program

View the Scientific Program

Accelerating AAV Gene Therapy: Innovations in Chemistry, Manufacturing, and Control

Adeno-associated virus (AAV) gene therapy has emerged as a transformative approach for treating a variety of genetic disorders. Many of these novel therapies are being developed to treat rare diseases with unmet medical needs, necessitating the rapid advancement through development and commercialization. The inherent complexity of AAV products has historically presented challenges in advancing the chemistry, manufacturing, and control (CMC) aspects commensurate with the pace of clinical development program. By attending this summit, you will connect virtually with a relevant global network and gain tangible knowledge to help you more quickly and robustly advance these transformative AAV therapies to patients who need them.

The NEW CGTP Fall Virtual Summit 2024 will bring together industry, regulatory, and academic professionals to discuss pertinent challenges in the AAV gene therapy field. The theme for this year is "Accelerating the Commercialization of AAV Gene Therapy Products: Advancements, Challenges and Opportunities in CMC". This one-day virtual program will include two sessions with speaker presentations and extended panel discussions. We look forward to an informative Summit and hope to see you there. Be ready to network, collaborate, and expand your knowledge.